SavedAdd your journal

Journals / Turkish Journal of Gastroenterology / 2010 / Cilt: 21 - Sayı: 1

Fatal hepatitis B reactivation in an immune patient after anti-leukemic chemotherapy (Letters to editore)

Bağışık olan bir hastada anti-lösemik tedavi sonrası ölümcül hepatit B reaktivasyonu (Editöre mektup)

Burcu ÇAKAR
Mehmet TURGUT
Ahmet BEKTAŞ
Müge USTAOĞLU
Tülay BAKIR
Pages
73–74
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ÇAKAR, B., TURGUT, M., BEKTAŞ, A., USTAOĞLU, M., BAKIR, T. (2022). Fatal hepatitis B reactivation in an immune patient after anti-leukemic chemotherapy (Letters to editore). Turkish Journal of Gastroenterology, Cilt: 21 - Sayı: 1, 73–74. https://ajindex.com/articles/606383

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Iannitto E, Minardi V, Calvaruso G, et al. Hepatitis B virus reactivation and alemtuzumab therapy. Eur J Haematol 2005; 74: 254-8
  2. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007; 136: 699-712
  3. Vassiliadis T, Garipidou V, Tziomalos K, et al. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series. Am J Hematol 2005; 80: 197-203
  4. Idilman R, Arat M, Soydan E, et al. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat 2004; 11: 141-7.